Sequana Medical N.V. (SEQUA) is a Medical devices company in the Healthcare sector, listed on Euronext Brussel. This page provides the complete earnings calendar, dividend schedule, and financial data for Sequana Medical N.V. in 2026. The next earnings report is expected on August 27, 2026.
Next earnings date
27 Aug 2026
In 7 days
EPS estimate
—
Revenue estimate
—
Past earnings
No dividend history available.
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Sequana Medical N.V. (SEQUA) is scheduled to report earnings on August 27, 2026.
Sequana Medical N.V. (SEQUA) last reported earnings on March 30, 2026.
Sequana Medical N.V. (SEQUA) is listed on Euronext Brussel.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.